{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:27Z","timestamp":1790655087355,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:00:00Z","timestamp":1295481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/hr.2010.277","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T07:02:20Z","timestamp":1295506940000},"page":"584-591","source":"Crossref","is-referenced-by-count":42,"title":["Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats"],"prefix":"10.1038","volume":"34","author":[{"given":"Shinpei","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hoyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Obata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Chinushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Hanawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifusa","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,20]]},"reference":[{"key":"BFhr2010277_CR1","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","volume":"110","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ . Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110: 1042\u20131046.","journal-title":"Circulation"},{"key":"BFhr2010277_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946\u2013952.","journal-title":"Circulation"},{"key":"BFhr2010277_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","volume":"113","author":"S Stewart","year":"2002","unstructured":"Stewart S, Hart CL, Hole DJ, McMurray JJ . A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study. Am J Med 2002; 113: 359\u2013364.","journal-title":"Am J Med"},{"key":"BFhr2010277_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB . Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22: 983\u2013988.","journal-title":"Stroke"},{"key":"BFhr2010277_CR5","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE . of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370\u20132375.","journal-title":"JAMA."},{"key":"BFhr2010277_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1067\/mhj.2002.122875","volume":"143","author":"AFFIRM Investigators","year":"2002","unstructured":"AFFIRM Investigators. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J 2002; 143: 991\u20131001.","journal-title":"Am Heart J"},{"key":"BFhr2010277_CR7","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","volume":"45","author":"JS Healey","year":"2005","unstructured":"Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ . Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005; 45: 1832\u20131839.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2010277_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","volume":"1","author":"S Nattel","year":"2008","unstructured":"Nattel S, Burstein B, Dobrev D . Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythmia Electrophysiol 2008; 1: 62\u201373.","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"BFhr2010277_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709\u2013717.","journal-title":"N Engl J Med"},{"key":"BFhr2010277_CR10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M . Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309\u20131321.","journal-title":"N Engl J Med"},{"key":"BFhr2010277_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","volume":"111","author":"GM Kuster","year":"2005","unstructured":"Kuster GM, Kotlyar E, Rude MK, Siwik DA, Liao R, Colucci WS, Sam F . Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation 2005; 111: 420\u2013427.","journal-title":"Circulation"},{"key":"BFhr2010277_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","volume":"47","author":"K Nagata","year":"2006","unstructured":"Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M . Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 2006; 47: 656\u2013664.","journal-title":"Hypertension"},{"key":"BFhr2010277_CR13","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT . Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 1992; 120: 893\u2013901.","journal-title":"J Lab Clin Med"},{"key":"BFhr2010277_CR14","first-page":"E657","volume":"269","author":"M Young","year":"1995","unstructured":"Young M, Head G, Funder J . Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995; 269: E657\u2013E662.","journal-title":"Am J Physiol"},{"key":"BFhr2010277_CR15","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1210\/en.2002-220120","volume":"143","author":"R Rocha","year":"2002","unstructured":"Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J, McMahon E . Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart. Endocrinology 2002; 143: 4828\u20134836.","journal-title":"Endocrinology"},{"key":"BFhr2010277_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/jmcc.2002.1526","volume":"34","author":"DB Sawyer","year":"2002","unstructured":"Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS . Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002; 34: 379\u2013388.","journal-title":"J Mol Cell Cardiol"},{"key":"BFhr2010277_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/hh1701.096615","volume":"89","author":"DR Pimentel","year":"2001","unstructured":"Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, Baliga R, Wang J, Siwik DA, Singh K, Pagano P, Colucci WS, Sawyer DB . Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001; 89: 453\u2013460.","journal-title":"Circ Res"},{"key":"BFhr2010277_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0022-2828(03)00084-1","volume":"35","author":"SH Kwon","year":"2003","unstructured":"Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS . H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003; 35: 615\u2013621.","journal-title":"J Mol Cell Cardiol"},{"key":"BFhr2010277_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/01.RES.0000204727.46710.5e","volume":"98","author":"PL Hordijk","year":"2006","unstructured":"Hordijk PL . Regulation of NADPH oxidases: the role of Rac proteins. Circ Res 2006; 98: 453\u2013462.","journal-title":"Circ Res"},{"key":"BFhr2010277_CR20","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI13350","volume":"108","author":"M Takemoto","year":"2001","unstructured":"Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, Kitakaze M, Liao JK . Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001; 108: 1429\u20131437.","journal-title":"J Clin Invest"},{"key":"BFhr2010277_CR21","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T . Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14: 1370\u20131376.","journal-title":"Nat Med"},{"key":"BFhr2010277_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1210\/en.2007-0864","volume":"149","author":"F Iwashima","year":"2008","unstructured":"Iwashima F, Yoshimoto T, Minami I, Sakurada M, Hirono Y, Hirata Y . Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology 2008; 149: 1009\u20131014.","journal-title":"Endocrinology"},{"key":"BFhr2010277_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.bbrc.2006.03.230","volume":"344","author":"W Mitsuma","year":"2006","unstructured":"Mitsuma W, Ito M, Kodama M, Fuse K, Okamura K, Minagawa S, Kato K, Hanawa H, Toba K, Nakazawa M, Aizawa Y . Cardioprotective effects of recombinant human erythropoietin in rats with experimental autoimmune myocarditis. Biochem Biophys Res Commun 2006; 344: 987\u2013994.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFhr2010277_CR24","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.carpath.2009.07.002","volume":"19","author":"M Hoyano","year":"2010","unstructured":"Hoyano M, Ito M, Kimura S, Tanaka K, Okamura K, Komura S, Mitsuma W, Hirono S, Chinushi M, Kodama M, Aizawa Y . Inducibility of atrial fibrillation depends not on inflammation but on atrial structural remodeling in rat experimental autoimmune myocarditis. Cardiovasc Pathol 2010; 19: e149\u2013e157.","journal-title":"Cardiovasc Pathol"},{"key":"BFhr2010277_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000218103","volume":"83","author":"K Okamura","year":"2009","unstructured":"Okamura K, Ito M, Tanaka K, Chinushi M, Adachi T, Mitsuma W, Hirono S, Nakazawa M, Kodama M, Aizawa Y . effects of olmesartan and azelnidipine on atrial structural remodeling in spontaneously hypertensive rats. Pharmacology 2009; 83: 360\u2013366.","journal-title":"Pharmacology"},{"key":"BFhr2010277_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/01.CIR.0000136088.18960.E6","volume":"110","author":"M Ito","year":"2004","unstructured":"Ito M, Adachi T, Pimentel DR, Ido Y, Colucci WS . Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism. Circulation 2004; 110: 412\u2013418.","journal-title":"Circulation"},{"key":"BFhr2010277_CR27","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/eurheartj\/ehi478","volume":"26","author":"P Milliez","year":"2005","unstructured":"Milliez P, Deangelis N, Rucker-Martin C, Leenhardt A, Vicaut E, Robidel E, Beaufils P, Delcayre C, Hatem SN . Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J 2005; 26: 2193\u20132199.","journal-title":"Eur Heart J"},{"key":"BFhr2010277_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1540-8167.2006.00372.x","volume":"17","author":"SC Shroff","year":"2006","unstructured":"Shroff SC, Ryu K, Martovitz NL, Hoit BD, Stambler BS . Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure. J Cardiovasc Electrophysiol 2006; 17: 534\u2013541.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"BFhr2010277_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000081267","volume":"73","author":"MI Wahed","year":"2005","unstructured":"Wahed MI, Watanabe K, Ma M, Yamaguchi K, Takahashi T, Tachikawa H, Kodama M, Aizawa Y . Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy. Pharmacology 2005; 73: 81\u201388.","journal-title":"Pharmacology"},{"key":"BFhr2010277_CR30","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","volume":"91","author":"DL Mann","year":"2002","unstructured":"Mann DL . Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002; 91: 988\u2013998.","journal-title":"Circ Res"},{"key":"BFhr2010277_CR31","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/eurheartj\/ehi350","volume":"26","author":"MD Engelmann","year":"2005","unstructured":"Engelmann MD, Svendsen JH . Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083\u20132092.","journal-title":"Eur Heart J"},{"key":"BFhr2010277_CR32","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","volume":"50","author":"TT Issac","year":"2007","unstructured":"Issac TT, Dokainish H, Lakkis NM . Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007; 50: 2021\u20132028.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2010277_CR33","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","volume":"96","author":"A Frustaci","year":"1997","unstructured":"Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A . Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180\u20131184.","journal-title":"Circulation"},{"key":"BFhr2010277_CR34","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","volume":"108","author":"RJ Aviles","year":"2003","unstructured":"Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK . Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006\u20133010.","journal-title":"Circulation"},{"key":"BFhr2010277_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijcard.2003.12.028","volume":"98","author":"FW Asselbergs","year":"2005","unstructured":"Asselbergs FW, van den Berg MP, Diercks GF, van Gilst WH, Van Veldhuisen DJ . C-reactive protein and microalbuminuria are associated with atrial fibrillation. Int J Cardiol 2005; 98: 73\u201377.","journal-title":"Int J Cardiol"},{"key":"BFhr2010277_CR36","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","volume":"47","author":"M Nagase","year":"2006","unstructured":"Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T . Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006; 47: 1084\u20131093.","journal-title":"Hypertension"},{"key":"BFhr2010277_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","volume":"104","author":"E Harada","year":"2001","unstructured":"Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, Harada M, Mizuno Y, Nakayama M, Shimasaki Y, Ito T, Nakamura S, Kuwahara K, Saito Y, Nakao K, Ogawa H . Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 2001; 104: 137\u2013139.","journal-title":"Circulation"},{"key":"BFhr2010277_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jacc.2007.03.041","volume":"50","author":"O Adam","year":"2007","unstructured":"Adam O, Frost G, Custodis F, Sussman MA, Sch\u00e4fers HJ, B\u00f6hm M, Laufs U . Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol 2007; 50: 359\u2013367.","journal-title":"J Am Coll Cardiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2010277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010277","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:06:58Z","timestamp":1684429618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2010277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,20]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["BFhr2010277"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.277","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,20]]}}}